Related Experiment Video
Updated: Jan 7, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Personalized Cancer Vaccines: Current Advances and Emerging Horizons
Lantian Lu1, Xuehan Lu2, Wei Luo1,3,4
1Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Personalized cancer vaccines, targeting unique tumor neoantigens, offer a promising frontier in oncology. Overcoming challenges in prediction and manufacturing is key to maximizing durable antitumor responses.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Personalized cancer vaccines leverage individual tumor profiles for targeted immune responses.
- Neoantigen-based vaccines are a rapidly advancing area in cancer immunotherapy.
Purpose of the Study:
- To provide a comprehensive overview of neoantigen-based personalized cancer vaccines.
- To discuss current landscape, future perspectives, and translational challenges.
Main Methods:
- Review of preclinical and clinical studies on various vaccine platforms (peptide, mRNA, DNA, dendritic cell, viral/bacterial vectors).
- Discussion of immune adjuvants, delivery systems, and combination strategies (e.g., with immune checkpoint inhibitors).
Main Results:
- Significant clinical progress has been made, but challenges persist.
- Key advances in vaccine platforms and combination strategies have been identified.
Conclusions:
- Predicting immunogenic neoantigens and streamlining manufacturing are critical hurdles.
- Biomarker-guided, mechanistically informed trials are essential for optimizing personalized cancer vaccines in precision immuno-oncology.
More Related Videos
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
07:33Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics
Cancer